21 November 2017 - On the same day as the European Council voted to move the EMA from London to Amsterdam, the UK Parliament issued a briefing paper on Brexit and medicines regulation.

The briefing paper summarises the current UK/EU regulatory framework for both medicines and medical devices, the impact of the relocation of the EMA, and options for future UK regulation post-Brexit. 

It is a briefing document, not a position paper, which draws together not only relevant legislation and guidance, but also statements and commentary from a number of sources, including the UK Secretary of State for Health (Jeremy Hunt), the UK Medicines and Healthcare Products Regulatory Agency, EMA, European Commission and press.

Read Lexology article